| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.67B | -3.7% |
| Gross profit | ¥1.04B | — |
| Operating income | ¥0.26B | — |
| Net income | ¥0.22B | -40.8% |
| Gross margin | 62.0% | Net margin 13.3% |
| Revenue Q/Q | +8.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.63B | 38.0% |
| R&D | ¥0.24B | 14.4% |
| SG&A | ¥0.38B | 22.5% |
| Tax & other | ¥0.04B | 2.5% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
南风股份 ・ 探路者 ・ 莱美药业 ・ 汉威科技 ・ 天海防务 ・ 安科生物 ・ ST豆神 ・ 鼎汉技术 ・ 华测检测 ・ 新宁物流 ・ 北陆药业 ・ 网宿科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies